|
業務類別
|
Biotechnology |
|
業務概覽
|
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates. |
| 公司地址
| 110 East 59th Street, New York, NY, USA, 10022 |
| 電話號碼
| +1 212 883-0200 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.royaltypharma.com |
| 員工數量
| 100 |
| Mr. Pablo Legorreta |
Chairman of the Board and Chief Executive Officer |
美元 937.50K |
10/04/2026 |
| Mr. Christopher Hite |
Executive Vice President and Vice Chairman |
美元 1.32M |
10/04/2026 |
| Mr. Terrance Coyne |
Principal Accounting Officer, Executive Vice President and Chief Financial Officer |
美元 1.32M |
10/04/2026 |
| Dr. Marshall Urist, M.D.,PhD |
Executive Vice President, Research and Investments |
美元 1.32M |
10/04/2026 |
| Mr. Arthur Richard McGivern |
Executive Vice President, Investments and General Counsel |
-- |
10/04/2026 |
|
|
| Mr. David C. Hodgson |
Independent Director |
10/04/2026 |
| Ms. Elizabeth H. Weatherman |
Independent Director |
10/04/2026 |
| Mr. Gregory Norden |
Independent Director |
10/04/2026 |
| Dr. Ted W. Love, M.D. |
Lead Independent Director |
10/04/2026 |
| Dr. Bonnie L. Bassler, PhD |
Independent Director |
10/04/2026 |
| Dr. Vlad Coric, M.D. |
Independent Director |
10/04/2026 |
| Dr. Carole Ho, M.D. |
Independent Director |
10/04/2026 |
| Mr. Pablo Legorreta |
Chairman of the Board and Chief Executive Officer |
10/04/2026 |
| Ms. Catherine M. Engelbert |
Independent Director |
10/04/2026 |
|
|
|
|
